InterMag
InterMag Inc. is a Seoul-based medical device company developing magnetically navigated micro-robot and catheter systems (RAMAN platform) for endovascular intervention and capsule endoscopy, targeting hospitals through direct enterprise sales of capital equipment with clinical validation partnerships in Korea.
- Company typePrivate
- Founded2008
- HeadquartersSeoul, South Korea
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What InterMag does
InterMag Inc., founded in 2008 and headquartered in Seoul, South Korea, is a privately held medical device company that develops magnetically navigated micro-robot and catheter systems for endovascular intervention and capsule endoscopy. Its core platform is the RAMAN (Robotically Assisted MAgnetic Navigation) system, which generates external magnetic fields (electromagnetic coils or permanent magnets) to remotely steer micro-robots and the distal ends of magnetic catheters or guidewires. The portfolio splits into two clinical product lines: the I-RAMAN System for endovascular intervention (targeting occlusive vascular disease treatment) and the C-RAMAN System for capsule endoscopy of the upper gastrointestinal tract, along with Feeding Robot, Micro-robot Type A (≤3 Fr), Micro-robot Type B (6-7 Fr), and a 3D Vascular Mapping Technology. Notable technical components include 8 electromagnetic coils generating a 110 mT ultra-strong magnetic field, a 7 DoF robot stage, X-ray machine compatibility, and modular architecture allowing use of conventional catheters and guidewires.
The company operates an enterprise field-sales go-to-market targeting hospitals and healthcare institutions directly, with clinical validation conducted through partnerships with Korean university hospitals including Hanyang University Hospital and Dongguk University Hospital. Revenue model is hardware sales of capital medical equipment (navigation systems, micro-robots, feeding robots) with quote-based enterprise pricing; revenue figures are not publicly disclosed. Manufacturing is supported by 2024 GMP certification, and the exploratory clinical trial plan for the magnetic navigation system and feeding robot was approved in 2024, indicating transition toward commercialization. Component manufacturing partnerships with CV Bio (peripheral guiding catheters and stents), OSY med (3Fr micro-catheters), and Intromedic (capsule endoscope with global sales network) anchor the supply chain, and selection into the MedTech Innovator Asia Pacific Accelerator 2024 provides visibility and potential non-dilutive funding. Founded by Gunhee Jang, Distinguished Professor at Hanyang University, the company has built its technology base on 16 years of university-led research with publications in IEEE Transactions journals (Mechatronics, Industrial Electronics).
InterMag firmographics
Firmographics- Name
- InterMag
- Legal name
- InterMag Inc.
- Website
- https://intermag.co.kr
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Short description
- InterMag Inc. is a Seoul-based medical device company developing magnetically navigated micro-robot and catheter systems (RAMAN platform) for endovascular intervention and capsule endoscopy, targeting hospitals through direct enterprise sales of capital equipment with clinical validation partnerships in Korea.
- Ownership category
- akta.pro rank
InterMag industry classification
Industry- Product category
- Medical Devices - Magnetic Surgical and Endoscopy Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
- akta.pro secondary industries
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where InterMag is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
InterMag business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of RAMAN system magnetic navigation systems, micro-robots, feeding robots, and related medical devices to hospitals and healthcare institutions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
InterMag product offering
Product offeringCore offering
InterMag manufactures and sells the RAMAN (Robotically Assisted MAgnetic Navigation) platform of medical devices for hospitals and healthcare institutions. The I-RAMAN System enables remote, X-ray radiation-free endovascular intervention by controlling external magnetic fields to steer micro-robots and magnetic catheters/guidewires, while the C-RAMAN System performs automated capsule endoscopy of the upper gastrointestinal tract using dual permanent magnet control. Supporting components include the Magnetic Navigation System (MNS), Feeding Robot, Micro-robot Type A (3 Fr), Micro-robot Type B (6-7 Fr), and Guiding Catheter.
Product overview
InterMag develops the RAMAN (Robotically Assisted MAgnetic Navigation System) platform consisting of two main product lines: I-RAMAN for endovascular intervention and C-RAMAN for capsule endoscopy. The I-RAMAN System provides magnetic navigation for vascular procedures with a core Magnetic Navigation System (MNS), Feeding Robot, and Micro-robots (Type A and Type B) that enable remote control of catheters and guidewires without X-ray radiation exposure. The C-RAMAN System provides full-automatic magnetic navigation for capsule endoscopy to examine the GI tract. Both systems use external magnetic fields generated by electromagnets or permanent magnets to control magnetic medical devices, offering a modular platform architecture where the navigation system serves as the core component and specialized robots provide therapeutic and delivery functions.
Differentiator
Problem solved
Functional benefit
Brands
- RAMAN System: Robotically Assisted MAgnetic Navigation SYSTEM - includes I-RAMAN for endovascular intervention and C-RAMAN for capsule endoscopy
- I-RAMAN
- C-RAMAN
Products and services
- I-RAMAN System Robotically Assisted MAgnetic Navigation System for endovascular intervention. Provides safe and accurate endovascular intervention for patients and X-ray radiation-free operating conditions for medical doctors by controlling external magnetic field to remotely control micro-robots and the distal part of magnetic catheters or guidewires. Features world-class ultra-strong magnetic field (110 mT), adjustable workspace for target lesions, X-ray machine compatibility, and lightweight portable design.
- C-RAMAN System Robotically Assisted MAgnetic Navigation System for Capsule Endoscopy. Examines the upper gastrointestinal tract (stomach, duodenum, and small intestine) accurately within a short period of time by controlling external magnetic field to control the motion of a capsule endoscope. Features upper magnet control with 150mm permanent magnets (5 DoF), lower magnet control with 80mm permanent magnets (5 DoF), and a patient bed accommodating patients up to 2m tall.
- Feeding Robot Consists of feeding part and treatment part, compatible with conventional catheters and guidewires, capable of selective control of multiple catheters and guidewires. Performs therapeutic functions including suction of blood clot debris, drug/contrast agent delivery, and ballooning.
- Micro-robot Type A General/micro endovascular intervention micro-robot incorporating all therapeutic functions of conventional catheters, enabling steering using external magnetic fields. Maximizes tunneling performance, allows selective separation and recombination, and facilitates drug and contrast agent delivery. Outer diameter ≤ 3 Fr (1mm), inner diameter ≥ 0.4mm.
- Micro-robot Type B Micro-robot and guiding catheter for treatment of occlusive vascular disease (OVD). Includes safety balloon design to prevent embolism and loss of micro-robot, plus screw mechanism for separation and recombination. Outer diameter 6 Fr (2mm) to 7 Fr (2.3mm). The guiding catheter handles delivery/retrieval, contrast agent and drug delivery, and suction to prevent embolism.
- Magnetic Navigation System (MNS) Generates an external magnetic field for remote control of magnetic catheters and micro-robots (steering and tunneling). Handles insertion and removal of guiding catheters and micro-robots, performs therapeutic functions (drug delivery, balloon expansion, suction), and maintains compatibility with conventional medical devices (sheath, guidewires).
Quantifiable outcome
- World's first micro-robot with 3 Fr diameter developed in 2019
- +3 more outcomes
Companies that use InterMag
Customer profileSegments2 records
Ideal customer profiles2 records
InterMag technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
InterMag partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Hanyang University Hospital (Seoul/Guri)coreR&D network partnership for clinical validation with Dr. Yeonghyo Lim and Dr. Yonggu Lee (Cardiology), Dr. Gyuseon Choi (Neurosurgery), Dr. Jeonggi Jo (Urology), Dr. Sujin Hong (Radiology), Dr. Jaehun Yun (Gastroenterology)
- Dongguk University HospitalcoreR&D network partnership with Dr. Yunjeong Im (Gastroenterology) for development and testing
- CV Bio InccorePartner manufacturer of guiding catheter for peripheral blood vessels and stent for peripheral blood vessels
- OSY med InccorePartner manufacturer of micro catheter (3Fr) and catheter and sheath products
- Intromedic InccorePartner manufacturer of capsule endoscope for GI tracts, maintaining global sales network of capsule endoscope
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
InterMag competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Diversified medical device leader with major franchises in interventional cardiology (including the Hugo robotic-assisted surgery system) and endoscopy. Operates in both core target markets of InterMag with deeper regulatory and commercial infrastructure.
- Olympus: Global leader in endoscopic imaging systems and therapeutic endoscopy devices. Comparable to the C-RAMAN side of InterMag, although Olympus's portfolio does not currently include magnetically steered capsule endoscopy.
- Intuitive Surgical: Dominant surgical robotics company (da Vinci, Ion) with broad minimally invasive surgery and image-guided bronchoscopy platforms. Comparable as a medical robotics incumbent that increasingly competes in catheter/endoluminal procedures adjacent to InterMag's I-RAMAN.
- Boston Scientific: Major player in endoscopy, interventional cardiology, and peripheral vascular devices. Relevant because its existing cardiology, endovascular, and endoscopy franchises overlap with InterMag's I-RAMAN and C-RAMAN target markets.
- Johnson & Johnson (Auris Health / Monarch): Through Auris Health's Monarch platform, J&J offers robotic bronchoscopy; broadly applies robotic endoluminal navigation to lung procedures, a closely adjacent indication family to InterMag's GI capsule and endovascular interventions.
Direct peers
- Stereotaxis: US-listed developer of magnetic navigation systems (Niobe/Genesis) for cardiac ablation and endovascular procedures. Directly comparable because both companies use externally generated magnetic fields to steer interventional devices inside the body.
- CapsoVision: Developer of CapsoCam, a small-bowel capsule endoscopy system. Competes with InterMag in the capsule endoscopy space, albeit without magnetic steering, but targets the same gastroenterology use case.
- Microbot Medical: Israel-based company developing the LIBERTY endovascular robotic system and self-disaggregating micro-robots for neurovascular and peripheral vascular interventions. Directly overlaps InterMag on remotely controlled micro-robots for endovascular use.
- AnX Robotica: Developer of magnetically controlled capsule endoscopy systems (Navicam) for GI examination. Directly comparable to InterMag's C-RAMAN product line, both relying on external magnets to maneuver capsule endoscopes through the GI tract.
Others
- Hanyang University Medical Center / Korean hospital networks: InterMag's clinical R&D partners (Hanyang University Hospital and Dongguk University Hospital). They are not commercial peers but represent the hospital-side ecosystem where comparable clinical validation studies for magnetic navigation and capsule endoscopy occur.
Market position
Strengths5 records
Weaknesses6 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
InterMag compliance and trust
Trust signalCompliance1 record
InterMag financial estimates
Financial estimateRevenue estimate
Valuation estimate
InterMag leadership team
Management profileNumber of profiles
Profiles1 record
InterMag funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InterMag M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InterMag
What does InterMag do?
InterMag manufactures and sells the RAMAN (Robotically Assisted MAgnetic Navigation) platform of medical devices for hospitals and healthcare institutions. The I-RAMAN System enables remote, X-ray radiation-free endovascular intervention by controlling external magnetic fields to steer micro-robots and magnetic catheters/guidewires, while the C-RAMAN System performs automated capsule endoscopy of the upper gastrointestinal tract using dual permanent magnet control. Supporting components include the Magnetic Navigation System (MNS), Feeding Robot, Micro-robot Type A (3 Fr), Micro-robot Type B (6-7 Fr), and Guiding Catheter.
Is InterMag a public or private company?
InterMag is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was InterMag founded?
InterMag was founded in 2008.
Where is InterMag based?
InterMag is headquartered in Seoul, South Korea, in the Asia region.
How does InterMag make money?
One revenue line is on record: medical Device Sales.
Who are InterMag's main competitors?
Broad incumbents on record are Medtronic, Olympus, Intuitive Surgical, Boston Scientific and Johnson & Johnson (Auris Health / Monarch). Direct peers are Stereotaxis, CapsoVision, Microbot Medical and AnX Robotica. Hanyang University Medical Center / Korean hospital networks is listed as an others.
Does InterMag have an API?
No public API is recorded for InterMag.
What industry is InterMag in?
InterMag's product category is Medical Devices - Magnetic Surgical and Endoscopy Robotics. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation). Its NAICS code is 339112 and its SIC code is 3841.